Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer.

Lavallée LT, McAlpine K, Kapoor A, Pouliot F, Mason R, Violette PD, Bansal RK, Richard PO, Karakiewicz PI, Bhindi B, Maloni R, Pautler S, Lattouf JB, Kassouf W, Tanguay S, So A, Rendon RA, Breau RH.

Can Urol Assoc J. 2019 Dec;13(12):377-383. doi: 10.5489/cuaj.6176. Epub 2019 Sep 17. No abstract available.

2.

Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.

Kushnir I, Kirk L, Mallick R, Kim RH, Graham GE, Breau RH, Lattouf JB, Violette PD, Pautler SE, Care M, Kapoor A, Jewett MAS, Wood L, Tanguay S, Heng DYC, Basappa NS, So A, Pouliot F, Reaume NM.

Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e10-e15. doi: 10.1016/j.clon.2019.07.010. Epub 2019 Aug 1.

PMID:
31378448
3.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.

4.

Editorial Comment.

Bjazevic J, Pautler SE.

Urology. 2019 Apr;126:108-109. doi: 10.1016/j.urology.2018.11.054. No abstract available.

PMID:
30929683
5.

Hydro-Jet Dissection of the Cavernous Nerves Preserves Erection Function in a Radical Prostatectomy Animal Model.

Campbell JD, Alenezi H, DeYoung LX, Brock GB, Pautler SE.

Sex Med. 2019 Mar;7(1):104-110. doi: 10.1016/j.esxm.2018.11.006. Epub 2019 Jan 21.

6.

AUTHOR REPLY.

Welk B, Pautler S.

Urology. 2018 Nov;121:145-146. doi: 10.1016/j.urology.2018.07.051. No abstract available.

PMID:
30526902
7.

Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.

Broeke NC, Peterson J, Lee J, Martin PR, Farag A, Gomez JA, Moussa M, Gaed M, Chin J, Pautler SE, Ward A, Bauman G, Bartha R, Scholl TJ.

J Magn Reson Imaging. 2019 May;49(5):1409-1419. doi: 10.1002/jmri.26336. Epub 2018 Nov 14.

PMID:
30430700
8.

A Population-Based Cohort Study of the Impact of Infectious Complications Requiring Hospitalization after Prostate Biopsy on Radical Prostatectomy Surgical Outcomes.

Olvera-Posada D, Welk B, McClure JA, Winick-Ng J, Izawa JI, Pautler SE.

Urology. 2018 Nov;121:139-146. doi: 10.1016/j.urology.2018.07.049. Epub 2018 Aug 29.

PMID:
30171923
9.
10.

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.

Correa RJM, Ahmad B, Warner A, Johnson C, MacKenzie MJ, Pautler SE, Bauman GS, Rodrigues GB, Louie AV.

Radiat Oncol. 2018 Mar 20;13(1):47. doi: 10.1186/s13014-018-0992-3.

11.

The impact of patient-, disease-, and treatment-related factors on survival in patients with adrenocortical carcinoma.

Punjani N, Clark R, Izawa J, Chin J, Pautler SE, Power N.

Can Urol Assoc J. 2018 Apr;12(4):98-103. doi: 10.5489/cuaj.4650. Epub 2017 Dec 22.

12.

[18F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.

Bauman G, Martin P, Thiessen JD, Taylor R, Moussa M, Gaed M, Rachinsky I, Kassam Z, Chin J, Pautler S, Lee TY, Valliant JF, Ward A.

Eur Urol Focus. 2018 Sep;4(5):702-706. doi: 10.1016/j.euf.2016.10.002. Epub 2016 Oct 26.

PMID:
28753797
13.

Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative.

Bansal RK, Tanguay S, Finelli A, Rendon R, Moore RB, Breau RH, Lacombe L, Black PC, Kawakami J, Drachenberg D, Pautler S, Saarela O, Liu Z, Jewett MAS, Kapoor A.

Can Urol Assoc J. 2017 Jun;11(6):182-187. doi: 10.5489/cuaj.4264.

14.

Author Reply.

Olvera-Posada D, Welk B, Pautler S.

Urology. 2017 Aug;106:131-132. doi: 10.1016/j.urology.2017.03.051. Epub 2017 Jun 1. No abstract available.

PMID:
28579213
15.

Vision-Based Surgical Field Defogging.

Luo X, McLeod AJ, Pautler SE, Schlachta CM, Peters TM.

IEEE Trans Med Imaging. 2017 Oct;36(10):2021-2030. doi: 10.1109/TMI.2017.2701861. Epub 2017 May 11.

PMID:
28504934
16.

The Impact of Multiple Prostate Biopsies on Risk for Major Complications Following Radical Prostatectomy: A Population-based Cohort Study.

Olvera-Posada D, Welk B, McClure JA, Winick-Ng J, Izawa JI, Pautler SE.

Urology. 2017 Aug;106:125-132. doi: 10.1016/j.urology.2017.03.048. Epub 2017 Apr 21.

PMID:
28438629
17.

Retained Digital Flexible Ureteroscopes.

Huynh M, Telfer S, Pautler S, Denstedt J, Razvi H.

J Endourol Case Rep. 2017 Feb 1;3(1):24-27. doi: 10.1089/cren.2017.0003. eCollection 2017.

18.

Structured assessment and followup for patients with hereditary kidney tumour syndromes.

Lattouf JB, Pautler SE, Reaume MN, Kim RH, Care M, Green J, So A, Violette PD, Saliba I, Major P, Silver S, Leicht R, Basiuk J, Tanguay S, Jewett MA, Drachenberg D; Kidney Cancer Research Network of Canada.

Can Urol Assoc J. 2016 Jul-Aug;10(7-8):E214-E222. doi: 10.5489/cuaj.3798. Epub 2016 Jul 12. Erratum in: Can Urol Assoc J. 2017 Aug;11(8):E325.

19.

KIM-1 Is a Potential Urinary Biomarker of Obstruction: Results from a Prospective Cohort Study.

Olvera-Posada D, Dayarathna T, Dion M, Alenezi H, Sener A, Denstedt JD, Pautler SE, Razvi H.

J Endourol. 2017 Feb;31(2):111-118. doi: 10.1089/end.2016.0215. Epub 2016 Dec 19.

PMID:
27852120
20.

The impact of teaching on the duration of common urological operations.

Welk B, Winick-Ng J, McClure A, Vinden C, Dave S, Pautler S.

Can Urol Assoc J. 2016 May-Jun;10(5-6):172-178.

21.

Combined Transurethral and Laparoscopic Partial Cystectomy and Robot-Assisted Bladder Repair for the Treatment of Bladder Mulerianosis.

Algreisi F, Vilos G, Oraif A, Vilos A, Pautler S.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S175-S176. doi: 10.1016/j.jmig.2015.08.649. Epub 2015 Oct 15. No abstract available.

PMID:
27678953
22.

Laser Laparascopy and Excision of Bladder Endometriosis With Operative Cystoscopy.

Algreisi F, Vilos G, Oraif A, Vilos A, Pautler S.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S156. doi: 10.1016/j.jmig.2015.08.589. Epub 2015 Oct 15. No abstract available.

PMID:
27678886
23.

Relative Contribution of Lateral Packing Density to Albumin Adsorption on Monolayers.

Safazadeh L, Zehuri VE, Pautler SP, Hastings JT, Berron BJ.

Langmuir. 2016 Aug 16;32(32):8034-41. doi: 10.1021/acs.langmuir.6b01885. Epub 2016 Aug 4.

PMID:
27463892
24.

Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.

Forbes CM, Rendon RA, Finelli A, Kapoor A, Moore RB, Breau RH, Lacombe L, Kawakami J, Drachenberg DE, Pautler SE, Jewett MMA, Saarela O, Liu Z, Tanguay S, Black PC.

Urol Oncol. 2016 Nov;34(11):486.e17-486.e23. doi: 10.1016/j.urolonc.2016.05.034. Epub 2016 Jul 14.

PMID:
27423824
25.

Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.

Gibson E, Bauman GS, Romagnoli C, Cool DW, Bastian-Jordan M, Kassam Z, Gaed M, Moussa M, Gómez JA, Pautler SE, Chin JL, Crukley C, Haider MA, Fenster A, Ward AD.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):188-96. doi: 10.1016/j.ijrobp.2016.04.018. Epub 2016 Apr 21.

PMID:
27375167
26.

Penile cancer: Perspective from a Canadian tertiary care centre.

Beech B, Izawa J, Pautler S, Chin J, Power N.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):315-9. doi: 10.5489/cuaj.3230.

27.

Independent predictors of prolonged operative time during robotic-assisted radical prostatectomy.

Violette PD, Mikhail D, Pond GR, Pautler SE.

J Robot Surg. 2015 Jun;9(2):117-23. doi: 10.1007/s11701-015-0497-0. Epub 2015 Feb 12.

PMID:
26531111
28.

Re: Saksens et al.: Dominant cystoid macular dystrophy (Ophthalmology 2015;122:180-91).

Pautler SE, Browning DJ.

Ophthalmology. 2015 Oct;122(10):e59-60. doi: 10.1016/j.ophtha.2015.02.042. No abstract available.

PMID:
26398057
29.

Quality of life after radical prostatectomy: Continuing to improve on our track record.

Chan G, Pautler SE.

Can Urol Assoc J. 2015 May-Jun;9(5-6):188-9. doi: 10.5489/cuaj.2999. No abstract available.

30.

Canadian guidelines for the management of small renal masses (SRM).

Jewett MA, Rendon R, Lacombe L, Karakiewicz PI, Tanguay S, Kassouf W, Leveridge M, Cagiannos I, Kapoor A, Pautler S, Drachtenberg D, Moore R, Gleave M, Evans A, Haider M, Finelli A.

Can Urol Assoc J. 2015 May-Jun;9(5-6):160-3. doi: 10.5489/cuaj.2969. No abstract available.

31.

Re: Impact of Macula-off Retinal Detachment on Visual Outcome, A Systematic Review and Meta-Analysis of Literature.

Browning DJ, Pautler SE, Wong KL, Telander DG, Stewart MW.

Retina. 2015 Jul;35(7):e44. doi: 10.1097/IAE.0000000000000673. No abstract available.

PMID:
26098277
32.

Surgical management of stage T1 renal tumours at Canadian academic centres.

Lavallée LT, Tanguay S, Jewett MA, Wood L, Kapoor A, Rendon RA, Moore RB, Lacombe L, Kawakami J, Pautler SE, Drachenberg DE, Black PC, Lattouf JB, Morash C, Cagiannos I, Liu Z, Breau RH.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):99-106. doi: 10.5489/cuaj.2598. Erratum in: Can Urol Assoc J. 2016 Aug;10 (7-8):E281.

33.

Re: Pachychoroid neovasculopathy.

Pautler SE, Browning DJ.

Retina. 2015 Jul;35(7):e39-40. doi: 10.1097/IAE.0000000000000661. No abstract available.

PMID:
26057392
34.

Near-infrared reflectance bull's eye maculopathy as an early indication of hydroxychloroquine toxicity.

Wong KL, Pautler SE, Browning DJ.

Clin Ophthalmol. 2015 Mar 19;9:521-5. doi: 10.2147/OPTH.S76963. eCollection 2015.

35.

Editorial comment.

Olvera-Posada D, Pautler SE.

Urology. 2015 Apr;85(4):849. doi: 10.1016/j.urology.2014.11.045. Epub 2015 Feb 11. No abstract available.

PMID:
25681248
36.

Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome.

Pautler SE, Browning DJ.

Clin Ophthalmol. 2014 Dec 30;9:43-9. doi: 10.2147/OPTH.S75448. eCollection 2015.

37.

Development of a novel classification system for anatomical variants of the puboprostatic ligaments with expert validation.

Kim M, Boyle SL, Fernandez A, Matsumoto ED, Pace KT, Anidjar M, Kozak GN, Davé S, Welk BK, Johnson MI, Pautler SE.

Can Urol Assoc J. 2014 Nov;8(11-12):432-6. doi: 10.5489/cuaj.1797.

38.

Robotic Proximal Ureteropyelostomy After Unsuccessful Endourologic Management of Complicated Proximal Ureteral Stone Disease.

Olvera-Posada D, Dion M, Alenezi H, Razvi H, Pautler SE.

J Endourol Case Rep. 2015 Oct 1;1(1):30-2. doi: 10.1089/cren.2015.29012.dop. eCollection 2015.

39.

Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey.

Violette PD, Kamel-Reid S, Graham GE, Reaume MN, Jewett MA, Care M, Basiuk J, Pautler SE.

Can Urol Assoc J. 2014 Nov;8(11-12):E832-40. doi: 10.5489/cuaj.2415.

40.

Endogenous biotin expression in renal and testicular tumours and literature review.

Fahmy N, Woo M, Alameldin M, Lee JK, MacDonald K, Goneau LW, Cadieux P, Burton J, Pautler S.

Can Urol Assoc J. 2014 Jul;8(7-8):268-72. doi: 10.5489/cuaj.1810.

41.

Predictive factors for return of erectile function in robotic radical prostatectomy: case series from a single centre.

Garcia FJ, Violette PD, Brock GB, Pautler SE.

Int J Impot Res. 2015 Jan-Feb;27(1):29-32. doi: 10.1038/ijir.2014.20. Epub 2014 Aug 7.

PMID:
25099635
42.

Topical lidocaine gel with and without subconjunctival lidocaine injection for intravitreal injection: a within-patient study.

Cohen SM, Billiris-Findlay K, Eichenbaum DA, Pautler SE.

Ophthalmic Surg Lasers Imaging Retina. 2014 Jul-Aug;45(4):306-10. doi: 10.3928/23258160-20140709-06.

PMID:
25037012
43.

Update on cryoablation for treatment of small renal mass: oncologic control, renal function preservation, and rate of complications.

Kapoor A, Wang Y, Dishan B, Pautler SE.

Curr Urol Rep. 2014 Apr;15(4):396. doi: 10.1007/s11934-014-0396-3. Review.

PMID:
24623576
44.

Ochratoxin A is not detectable in renal and testicular tumours.

Fahmy N, Woo M, Alameldin M, Macdonald K, Goneau LW, Cadieux P, Pautler SE.

Can Urol Assoc J. 2014 Jan-Feb;8(1-2):40-6. doi: 10.5489/cuaj.1240.

45.

Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada.

Organ M, Jewett M, Basiuk J, Morash C, Pautler S, Siemens DR, Tanguay S, Gleave M, Drachenberg D, Chow R, Chin J, Evans A, Fleshner N, Gallie B, Haider M, Kachura J, Finelli A, Rendon RA.

Can Urol Assoc J. 2014 Jan-Feb;8(1-2):24-7. doi: 10.5489/cuaj.1483.

46.

Combined transurethral and laparoscopic partial cystectomy and robotically assisted bladder repair for the treatment of bladder endocervicosis: case report and review of the literature.

Rajakumar C, Vilos GA, Vilos AG, Marks JL, Ettler HC, Pautler SS.

J Obstet Gynaecol Can. 2014 Feb;36(2):141-145. doi: 10.1016/S1701-2163(15)30660-5. Review.

PMID:
24518913
47.

3D prostate histology image reconstruction: Quantifying the impact of tissue deformation and histology section location.

Gibson E, Gaed M, Gómez JA, Moussa M, Pautler S, Chin JL, Crukley C, Bauman GS, Fenster A, Ward AD.

J Pathol Inform. 2013 Oct 31;4:31. doi: 10.4103/2153-3539.120874. eCollection 2013.

48.

Reporting the Canadian robotic experience: The outcomes and how we report them.

Pautler SE.

Can Urol Assoc J. 2013 Sep-Oct;7(9-10):333-4. doi: 10.5489/cuaj.1689. No abstract available.

49.

Canadian guideline on genetic screening for hereditary renal cell cancers.

Reaume MN, Graham GE, Tomiak E, Kamel-Reid S, Jewett MA, Bjarnason GA, Blais N, Care M, Drachenberg D, Gedye C, Grant R, Heng DY, Kapoor A, Kollmannsberger C, Lattouf JB, Maher ER, Pause A, Ruether D, Soulieres D, Tanguay S, Turcotte S, Violette PD, Wood L, Basiuk J, Pautler SE; Kidney Cancer Research Network of Canada.

Can Urol Assoc J. 2013 Sep-Oct;7(9-10):319-23. doi: 10.5489/cuaj.1496.

50.

Effect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: A systematic review.

Fahmy N, Lazo-Langner A, Iansavichene AE, Pautler SE.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E740-9. doi: 10.5489/cuaj.1213. Review.

Supplemental Content

Loading ...
Support Center